 cAMP is the second messenger that controls the level of calcium available to allow the heart to contract.An IV administration of amrinone has been shown to increase cardiac output (CO) and stroke volume (SV) while concurrently reducing the filling pressure of the left ventricle and decreasing the resistance in the peripheral vasculature.This does not lead to an increase in heart rate or blood pressure.